Our ROC analysis suggested that plasma NfL is less sensitive for detecting early neurodegeneration in this cohort, with 55 preHD values (87%) within the 95th control percentile; this is in contrast to the near-equivalence of CSF and plasma NfL in manifest Huntington's disease. The gene discussed is NEFL; the disease is juvenile Huntington disease.